Integrated BioPharma (OTCMKTS:INBP) Trading Up 8.8% – What’s Next?

Shares of Integrated BioPharma Inc. (OTCMKTS:INBP) traded up 8.8% on Monday . The stock traded as high as $0.31 and last traded at $0.31. 11,028 shares were traded during trading, a decline of 54% from the average session volume of 23,854 shares. The stock had previously closed at $0.2850.

Integrated BioPharma Stock Down 6.5%

The company has a debt-to-equity ratio of 0.01, a current ratio of 4.12 and a quick ratio of 1.92. The firm has a market cap of $8.98 million, a P/E ratio of 29.03 and a beta of 0.47. The firm’s 50-day moving average price is $0.30 and its 200 day moving average price is $0.30.

Integrated BioPharma (OTCMKTS:INBP) last announced its quarterly earnings data on Tuesday, September 23rd. The company reported ($0.01) earnings per share (EPS) for the quarter. The firm had revenue of $14.18 million for the quarter. Integrated BioPharma had a return on equity of 3.32% and a net margin of 1.26%.

Integrated BioPharma Company Profile

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.